News

Article

MJH Life Sciences, parent of Ophthalmology Times, acquires EnVision Summit

The Eye Care Network adds a longstanding, CME-certified to its live event programming.

MJH Life Sciences acquires EnVision Summit - ©dennisvdwater

Image credit: Adobe Stock/dennisvdwater

MJH Life Sciences, parent company of Ophthalmology Times, has acquired The EnVision Summit. The meeting, held annually in Puerto Rico, combines an innovative CME-certified education program with a first-class family experience.

The summit will be hosted as a CME-certified conference within the Physicians’ Education Resource® legacy portfolio, supported by the care network brands Ophthalmology Times and Optometry Times. MJH Life Sciences noted in a press release that the acquisition aligns with its long-term growth strategy supported by a strategic partnership with BDT & MSD Partners.

The holistic approach to the summit includes age-appropriate activities for participants' family members, including children. In 2024, the EnVision Summit debuted an optometry track concurrent with the existing ophthalmology sessions.

Bonnie An Henderson, MD, the EnVision Summit director and cofounder, expressed enthusiasm about the future of the summit under MJH Life Sciences’ leadership. Henderson, President and CEO of global nonprofit HelpMeSee, as well as a past president of the American Society of Cataract and Refractive Surgery.

“I am thrilled about the possibilities that this acquisition brings for the EnVision Summit,” Henderson said. “With the resources and expertise of MJH Life Sciences, we will be able to elevate our educational offerings to new heights, ensuring that eye care professionals worldwide have access to the most current and comprehensive information in multiple channels to better serve their patients. I look forward to continuing as the Program Director to maintain the excellence of the content and faculty.”

Mike Hennessy Jr., president and CEO of MJH Life Sciences, commented on the news, describing it as a continuation of MJH Life Sciences’ mission. “As we continue to expand our commitment to education in the eye care space, the acquisition of EnVision Summit allows us to build on the strong foundation we’ve established with our leading brands,” he said. “The summit and its hundreds of loyal attendees will benefit not only from our expertise in providing engaging educational experiences on cutting-edge topics, but also from new and expanded opportunities to help them address the rapidly evolving ophthalmic landscape.”

The upcoming EnVision Summit is scheduled for February 14-17, 2025, at the Caribe Hilton, San Juan, Puerto Rico

Ophthalmology Times has previously covered the EnVision Summit. In our archives, we have an interview with Henderson prior to the 2024 Summit, as well as conversations with speakers on key takeaways from their presentations as well as with attendees on what makes the meeting so special.

To learn more and to register for the event, please visit www.envisionsummit.org.

Reference:
  1. MJH Life Sciences® acquires EnVision Summit, expands leadership in eye care education. MJH Life Sciences. Press release. Accessed October 9, 2024.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
© 2025 MJH Life Sciences

All rights reserved.